Executives On The Move: CEOs Welcomed At Cadent Therapeutics And Enzyvant Sciences, And Top Development Spot Filled At Bicycle Therapeutics
Executive Summary
A new CEO for movement and cognitive disorder company Cadent Therapeutics, and Alexion SVP departs for CEO position at rare disease therapy firm Enzyvant Sciences. Plus transatlantic biotech Bicycle Therapeutics appoints a CBO, while Simon Moroney announces his departure from MorphoSys.